What caused Clearbridge Health's 100% surge?

The precise catalyst is unclear, but speculative trading and low participation volume may have influenced the price jump in Clearbridge Health Limited.

Is Clearbridge Health financially stable?

The company faces financial challenges, with negative earnings per share and a low book value per share. It has a high debt-to-equity ratio of 0.12, indicating financial strain.

What does Meyka AI's rating indicate?

Meyka AI assigns Clearbridge Health a score of 55.0, grade C+, suggesting a HOLD position. The rating considers sector performance, financial metrics, and future forecasts.

What are the long-term projections for Clearbridge Health?

Meyka AI forecasts suggest potential growth to S$0.021 in five years, but current projections indicate limited short-term upside at S$0.00204 for the year.

Should I invest in Clearbridge Health now?

Investment decisions should consider the HOLD rating from Meyka AI, financial health, sector conditions, and personal risk tolerance. Consultation with a financial advisor is recommended.

SG Stocks

1H3.SI Pre-Market (26 Dec 2025): Clearbridge Health’s 100% Price Jump

ByHuzaifa Zahoor December 26, 2025December 26, 2025

Clearbridge Health Limited (SES:1H3.SI) has captured investor attention with a striking 100% increase in pre-market trading, settling at S$0.002. While the healthcare sector faces challenging economic conditions, this movement merits a closer examination.